Related Experiment Video
Updated: Apr 6, 2026

Enrichment of Bacterial Lipoproteins and Preparation of N-terminal Lipopeptides for Structural Determination by Mass Spectrometry
Published on: May 21, 2018
N-Lipidated Peptide Dimers: Effective Antibacterial Agents against Gram-Negative Pathogens through Lipopolysaccharide
Jun-Jie Koh1,2, Huifen Lin1, Vonny Caroline1
1Singapore Eye Research Institute, The Academia , 20 College Road, Discovery Tower Level 6, 169856, Singapore.
Abstract:
Treating infections caused by multidrug-resistant Gram-negative pathogens is challenging, and there is concern regarding the toxicity of the most effective antimicrobials for Gram-negative pathogens. We hypothesized that conjugating a fatty acid moiety onto a peptide dimer could maximize the interaction with lipopolysaccharide (LPS) and facilitate the permeabilization of the LPS barrier, thereby improving potency against Gram-negative pathogens. We systematically designed a series of N-lipidated peptide dimers that are active against Gram-negative bacteria, including carbapenem-resistant Enterobacteriaceae (CRE). The optimized lipid length was 6-10 carbons. At these lipid lengths, the N-lipidated peptide dimers exhibited strong LPS permeabilization. Compound 23 exhibited synergy with select antibiotics in most of the combinations tested. 23 and 32 also displayed rapid bactericidal activity. Importantly, 23 and 32 were nonhemolytic at 10 mg/mL, with no cellular or in vivo toxicity. These characteristics suggest that these compounds can overcome the limitations of current Gram-negative-targeted antimicrobials such as polymyxin B.
Insights
New peptide dimers with fatty acid chains show potent activity against multidrug-resistant Gram-negative bacteria. These compounds effectively permeabilize the lipopolysaccharide (LPS) barrier and demonstrate low toxicity, offering a promising alternative to existing antibiotics.
Area of Science:
- Medicinal Chemistry
- Microbiology
- Drug Discovery
Background:
- Treating multidrug-resistant Gram-negative infections is challenging due to pathogen resistance and antimicrobial toxicity.
- Existing treatments like polymyxin B have limitations regarding toxicity and efficacy.
Purpose of the Study:
- To design and synthesize novel N-lipidated peptide dimers to combat Gram-negative pathogens.
- To enhance antimicrobial potency by maximizing interaction with lipopolysaccharide (LPS) and facilitating LPS barrier permeabilization.
Main Methods:
- Systematic design and synthesis of a series of N-lipidated peptide dimers.
- Evaluation of LPS permeabilization and antimicrobial activity against Gram-negative bacteria, including carbapenem-resistant Enterobacteriaceae (CRE).
- Assessment of synergistic effects with existing antibiotics and evaluation of toxicity (hemolytic, cellular, in vivo).
Main Results:
- Optimized lipid chain length (6-10 carbons) demonstrated strong LPS permeabilization.
- Developed compounds, particularly compound 23, showed synergy with antibiotics and rapid bactericidal activity.
- Compounds 23 and 32 exhibited no hemolytic, cellular, or in vivo toxicity at tested concentrations.
Conclusions:
- N-lipidated peptide dimers represent a promising new class of antimicrobials against multidrug-resistant Gram-negative pathogens.
- These compounds overcome limitations of current therapies by effectively targeting the LPS barrier with low toxicity.
- Further development of these peptide dimers could provide a vital new strategy for treating challenging Gram-negative infections.
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Formation of Lipopolysaccharides
Bacterial Cell Wall
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Inhibitors of Bacterial Protein Synthesis
Peptidoglycan Synthesis

